サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390621

キャリアスクリーニング市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Carrier Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
キャリアスクリーニング市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界のキャリアスクリーニング市場規模は2022年に17億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに31億米ドルに達し、2022年から2028年の間に10.53%の成長率（CAGR）を示すと予測しています。

キャリアスクリーニングは、常染色体劣性遺伝性疾患の原因となる胎児の異常遺伝子を特定するために用いられる遺伝子検査技術です。これは、妊娠中の個人やカップルが、子供が両親から遺伝性疾患を受け継ぐリスクを分析するために使用される、予測的で症状発現前の検査ソリューションです。嚢胞性線維症、鎌状赤血球貧血、テイ・サックス病などの疾患の異常遺伝子の存在を検出するために、唾液、血液、頬の組織のサンプルを検査します。これらのサンプルは、デオキシリボ核酸（DNA）シークエンシング、ポリメラーゼ連鎖反応（PCR）、マイクロアレイ技術に基づく分子生化学的プロセスによってスクリーニングされます。これらのサンプルは、さまざまな肺疾患、血液疾患、神経疾患に対する拡大、カスタマイズパネル、事前設計パネル、標的疾患キャリアスクリーニングに使用されます。

キャリアスクリーニング市場の動向：

世界中で胎児の染色体異常や遺伝性疾患の有病率が増加していることは、市場の成長を促進する重要な要因の一つです。さらに、疾病の早期発見・診断の利点に関する大衆の意識の高まりが、市場の成長を後押ししています。これに伴い、分子スクリーニング検査は、遺伝子コード中のDNA変異を特定し、心臓障害、白血病予備軍、聴覚障害、ダウン症の原因となる変異を検出するために広く実施されています。また、キャリアスクリーニングは、適切な出生前ケアや生殖ケアを提供するのに役立ち、遺伝性疾患の適切な管理を促進します。さらに、遺伝性疾患スクリーニングのための次世代シーケンサー（NGS）技術の開拓など、さまざまな技術の進歩も市場の成長を後押ししています。その他の要因としては、バイオテクノロジーやバイオインフォマティクスの分野における広範な研究開発（R&D）活動、医療インフラの著しい成長などが挙げられ、市場の成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 世界のキャリアスクリーニング市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のキャリアスクリーニング市場に与えた影響は？
  • 主要な地域市場は？
  • タイプ別の市場内訳は？
  • 疾患別の市場内訳は？
  • 技術別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界のキャリアスクリーニング市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 キャリアスクリーニングの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 拡大キャリアスクリーニング
    • 市場動向
    • 主要セグメント
      • カスタマイズパネル検査
      • 設計済みパネル検査
    • 市場予測
  • ターゲット疾患キャリアスクリーニング
    • 市場動向
    • 市場予測

第7章 市場内訳：疾患別

  • 肺疾患
    • 市場動向
    • 市場予測
  • 血液疾患
    • 市場動向
    • 市場予測
  • 神経疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • DNAシーケンス
    • 市場動向
    • 市場予測
  • ポリメラーゼ連鎖反応
    • 市場動向
    • 市場予測
  • マイクロアレイ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • リファレンスラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Fulgent Genetics
    • Gene：By Gene Ltd.（MyDNA）
    • Illumina Inc.
    • Invitae Corporation
    • MedGenome Labs Ltd.
    • Myriad Genetics Inc.
    • Natera Inc.
    • OPKO Health Inc.
    • Quest Diagnostics
    • Sema4
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Carrier Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Carrier Screening Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Carrier Screening Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Carrier Screening Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Carrier Screening Market: Breakup by Medical Condition (in %), 2022
  • Figure 6: Global: Carrier Screening Market: Breakup by Technology (in %), 2022
  • Figure 7: Global: Carrier Screening Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Carrier Screening Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Carrier Screening (Expanded Carrier Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Carrier Screening (Expanded Carrier Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Carrier Screening (Targeted Disease Carrier Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Carrier Screening (Targeted Disease Carrier Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Carrier Screening (Pulmonary Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Carrier Screening (Pulmonary Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Carrier Screening (Hematological Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Carrier Screening (Hematological Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Carrier Screening (Neurological Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Carrier Screening (Neurological Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Carrier Screening (Other Medical Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Carrier Screening (Other Medical Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Carrier Screening (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Carrier Screening (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Carrier Screening (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Carrier Screening (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Carrier Screening (Microarrays) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Carrier Screening (Microarrays) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Carrier Screening (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Carrier Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Carrier Screening (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Carrier Screening (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Carrier Screening (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Carrier Screening (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Carrier Screening (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Carrier Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: North America: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: North America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: United States: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: United States: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Canada: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Canada: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Asia-Pacific: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Asia-Pacific: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: China: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: China: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Japan: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Japan: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: India: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: India: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: South Korea: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: South Korea: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Australia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Australia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Indonesia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Indonesia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Europe: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Europe: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Germany: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Germany: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: France: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: France: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: United Kingdom: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: United Kingdom: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Italy: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Italy: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Spain: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Spain: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Russia: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Russia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Latin America: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Latin America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Brazil: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Brazil: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Mexico: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Mexico: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Middle East and Africa: Carrier Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Middle East and Africa: Carrier Screening Market: Breakup by Country (in %), 2022
  • Figure 83: Middle East and Africa: Carrier Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Carrier Screening Industry: SWOT Analysis
  • Figure 85: Global: Carrier Screening Industry: Value Chain Analysis
  • Figure 86: Global: Carrier Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Carrier Screening Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Carrier Screening Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Carrier Screening Market Forecast: Breakup by Medical Condition (in Million US$), 2023-2028
  • Table 4: Global: Carrier Screening Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Carrier Screening Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Carrier Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Carrier Screening Market: Competitive Structure
  • Table 8: Global: Carrier Screening Market: Key Players
目次
Product Code: SR112023A4417

Abstract

The global carrier screening market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.53% during 2022-2028.

Carrier screening is a genetic testing technique used for the identification abnormal genes in fetuses that can cause autosomal recessive diseases. It is a predictive and pre-symptomatic testing solution used by pregnant individuals and couples to analyze the risks of their child inheriting genetic disorders from the parents. It involves testing a sample of saliva, blood or cheek tissue to detect the presence of an abnormal gene for disorders, such as cystic fibrosis, sickle cell anemia and Tay-Sachs disease. These samples are screened through molecular and biochemical processes based on deoxyribonucleic acid (DNA) sequencing, polymerase chain reaction (PCR) and microarray technologies. They are used for expanded, customized panel, predesigned panel and targeted disease carrier screening for various pulmonary, hematological and neurological disorders.

Carrier Screening Market Trends:

The increasing prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising consciousness among the masses regarding the benefits of early detection and diagnosis of diseases is providing a thrust to the market growth. In line with this, molecular screening tests are widely conducted to identify DNA mutations in the genetic codes and detect the mutations that can cause heart defects, pre-leukemia, hearing defects and down syndrome. Carrier screening also aids in providing adequate prenatal and reproductive care, which facilitates the proper management of heritable diseases. Additionally, various technological advancements, such as the development of next-generation sequencing (NGS) techniques for genetic disease screening, are also favoring the market growth. Other factors, including extensive research and development (R&D) activities in the field of biotechnology and bioinformatics, along with significant growth in the medical infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global carrier screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, medical condition, technology and end user.

Breakup by Type:

Expanded Carrier Screening

Customized Panel Testing

Predesigned Panel Testing

Targeted Disease Carrier Screening

Breakup by Medical Condition:

Pulmonary Conditions

Hematological Conditions

Neurological Conditions

Others

Breakup by Technology:

DNA Sequencing

Polymerase Chain Reaction

Microarrays

Others

Breakup by End User:

Hospitals and Clinics

Reference Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Fulgent Genetics, Gene By Gene Ltd. (MyDNA), Illumina Inc., Invitae Corporation, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Quest Diagnostics, Sema4 and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global carrier screening market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global carrier screening market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the medical condition?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global carrier screening market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Carrier Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Expanded Carrier Screening
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Customized Panel Testing
      • 6.1.2.2 Predesigned Panel Testing
    • 6.1.3 Market Forecast
  • 6.2 Targeted Disease Carrier Screening
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Medical Condition

  • 7.1 Pulmonary Conditions
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hematological Conditions
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Conditions
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 DNA Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Fulgent Genetics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Gene By Gene Ltd. (MyDNA)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Illumina Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Invitae Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 MedGenome Labs Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Myriad Genetics Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 OPKO Health Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Quest Diagnostics
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sema4
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis